OR WAIT 15 SECS
February 22, 2021
Operational and patient burden considerations for self-collection of blood specimens in clinical trials
February 12, 2021
A look forward to 2021 for the clinical trials industry.
December 16, 2020
EVP and General Manager of Hū, April Lewis, discusses why the industry has seen a decline in trial participation and what Hū is doing to combat it.
Regulatory concerns remain despite industry's quick adaptation of decentralized trials.
November 24, 2020
The industry wide shift to decentralized clinical trials includes considerations for sponsors and CROs such as global availability, global technology, and data integration.
November 18, 2020
Bayesian methods bring flexibility and speed to clinical trial design and analysis, and with increased access to the necessary computational power, are transforming today’s clinical research.
November 02, 2020
Both quality personnel and the FDA have predicted some of the issues with pandemic operations, but much is still unknown on the impact these rapidly implemented pandemic processes.
October 23, 2020
Randomized controlled trials establish strict inclusion and exclusion criteria in an effort to optimize the cohort of trial participants.
October 22, 2020
Findings from a Tufts study examining the effects of COVID-19 on clinical trials.
October 16, 2020
Tips for reducing site queries and improving workflows.